<DOC>
	<DOC>NCT01841450</DOC>
	<brief_summary>The purpose of this study is to assess the long-term safety of the Glaukos® iStent® Trabecular Micro-Bypass Stent Model GTS100 in conjunction with cataract surgery vs. cataract surgery only, in subjects with mild to moderate open-angle glaucoma.</brief_summary>
	<brief_title>Multicenter Post-Approval Study Of The Glaukos® iStent® Trabecular Micro-Bypass Stent System In Conjunction With Cataract Surgery</brief_title>
	<detailed_description>The purpose of this study is to assess the long-term safety of the Glaukos® iStent® Trabecular Micro-Bypass Stent Model GTS100 in conjunction with cataract surgery compared to cataract surgery only, in subjects with mild to moderate open-angle glaucoma.</detailed_description>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Cataract</mesh_term>
	<mesh_term>Glaucoma, Open-Angle</mesh_term>
	<criteria>mild to moderate primary openangle glaucoma currently treated with ocular hypotensive medication pseudoexfoliative and pigmentary glaucoma are acceptable diagnoses subject scheduled to undergo cataract surgery primary angleclosure glaucoma; or secondary angle closure glaucoma, including neovascular glaucoma retrobulbar tumor, thyroid eye disease, SturgeWeber syndrome or any other type of condition that may cause elevated episcleral venous pressure</criteria>
	<gender>All</gender>
	<minimum_age>22 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Primary open-angle glaucoma (POAG)</keyword>
	<keyword>Trabecular meshwork</keyword>
	<keyword>iStent</keyword>
</DOC>